Global Arrhythmia Market Size and Forecast 2024-2033|Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, AliveCor Inc., Biotronik SE & Co. KG

3D Illustration Concept of Human Circulatory System Heart Anatomy

The Arrhythmia Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Arrhythmia Market:

https://www.thebusinessresearchcompany.com/report/arrhythmia-global-market-report

According to The Business Research Company’s Arrhythmia Global Market Report 2024, The arrhythmia market size has grown strongly in recent years. It will grow from $7.43 billion in 2023 to $8.01 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increased lifestyle-related risk factors, rise in cardiovascular diseases, improvements in implantable devices, global increase in cardiac surgery, growing demand for remote monitoring, research and development in antiarrhythmic drugs.

The arrhythmia market size is expected to see strong growth in the next few years. It will grow to $10.93 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to expanding awareness and education, personalized medicine approaches, expansion of electrophysiology labs, focus on early detection and prevention, genetic screening for familial arrhythmias, healthcare infrastructure development.. Major trends in the forecast period include advancements in cardiac monitoring technologies, telehealth and remote patient monitoring, focus on atrial fibrillation (af) detection and management, implantable devices for arrhythmia management, innovations in ecg monitoring devices, regulatory focus on medical device approvals.

The rising prevalence of cardiac disease and other heart problems is expected to propel the growth of the arrhythmia market going forward. Cardiac disease or cardiovascular disease refers to a collection of heart and blood vessel conditions, including several conditions such as atherosclerosis, heart attack, stroke, and arrhythmia, among others. Both functional defects, including diastolic and systolic dysfunction, and electrical defects, including the development of arrhythmias, can result in a high prevalence of heart failure, atrial fibrillation, and other cardiovascular diseases. For instance, in October 2022, according to the CDC (Centers for Disease Control and Prevention), a US-based government agency, every year in the United States, there were estimated to be 69.7k heart disease-related deaths and 80.5k heart attacks every year. [i] Thus, the rising prevalence of cardiac disease and other heart problems is driving the growth of the arrhythmia market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=8018&type=smp

The arrhythmia market covered in this report is segmented –

1) By Type: Supraventicular Tachycardias, Ventricular Arrhythmias, Bradyarrhythmias, Other Types

2) By Test Equipment: Electrocardiogram (ECG), Holter Monitor

3) By Hearth blocks: First degree heart block, Second degree heart bloc, Third Degree heart block

4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

New therapies for treatment are a key trend in the arrhythmia market. Major players operating in the market are advancing toward developing new therapies, such as cryoablation therapy, an innovative treatment used in patients with arrhythmias. For instance, in November 2021, Aster Medcity, an India-based quaternary care healthcare center, launched the state-of-the-art heart disease treatment Cryoablation Therapy, an innovative procedure that inhibits abnormal electrical pathways that cause strokes and heart failures and restores a normal heartbeat. Using advanced imaging technology, the catheter is passed through a blood vessel in the patient’s leg and routed to the heart. Nitrous oxide gas is injected into a cryoballoon, which cools the tissue and produces ablation lesions inside the heart. By using a balloon and a low temperature, this treatment is capable of completing the process without damaging other cells.

The arrhythmia market report table of contents includes:

1. Executive Summary

2. Arrhythmia Market Characteristics

3. Arrhythmia Market Trends And Strategies

4. Arrhythmia Market – Macro Economic Scenario

5. Global Arrhythmia Market Size and Growth

26. South America Arrhythmia Market

27. Brazil Arrhythmia Market

28. Middle East Arrhythmia Market

29. Africa Arrhythmia Market

30. Arrhythmia Market Competitive Landscape And Company Profiles

Top Major Players: